PRE 14A

PRE 14A Filing

Company: Oncotelic Therapeutics, Inc.
Filed: October 18, 2019
Period of Report: October 18, 2019
Accession Number: 0001493152-19-015670

View Document ↗ View on SEC.gov ↗